What We're Reading: Page 173
Industry reads hand-picked by our editors
Sep 14, 2020
-
360Dx
Labs Struggling to Comply With UnitedHealthcare Test Registry Requirements
-
Reuters
Hospital ICUs lean on telemedicine amid U.S. COVID-19 crisis
-
MedCity News
MDLive raises $50M to build out telehealth platform
-
MobiHealthNews
Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal
Sep 11, 2020
-
STAT
Doctors are increasingly using remote monitoring technology, raising questions about inclusivity and usability
-
Healthcare Dive
Targeted cyberattacks on telehealth vendors skyrocketed along with adoption, report finds
-
MobiHealthNews
With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, logistical
Sep 10, 2020
-
360Dx
Verily Life Sciences Coronavirus Test Gets FDA Emergency Use Authorization
-
The New York Times
Coronavirus Tests Are Supposed to Be Free. The Surprise Bills Come Anyway.
-
Diagnostic and Interventional Cardiology
Society of Interventional Radiology publishes IVC filter guidelines
-
The New England Journal of Medicine
Covid-19 Molecular Diagnostic Testing — Lessons Learned
Sep 09, 2020
Sep 08, 2020
-
Wall Street Journal
Labs Struggled With Surge in Covid-Testing Demand; How One Made It Through
-
Healthcare Dive
MedPAC commissioners hint at telehealth policies that may stick post-COVID-19
-
AP News
Bold hopes for virus antibody tests still unfulfilled
-
The New York Times
Daily Coronavirus Testing at Home? Many Experts Are Skeptical
Sep 04, 2020
-
Wall Street Journal
Covid-19 Positivity Rate Might Not Mean What You Think It Does
-
Evaluate Vantage
Medtechs that book the most sales per employee face the greatest losses
-
The Boston Globe
Boston startup Biofourmis raises $100m for remote medical tech
Sep 03, 2020
-
Verdict Medical Devices
CryoLife buys Ascyrus Medical to expand presence in aortic market
-
The Hill
Google Cloud awarded defense contract for cancer research
-
The New Yorker
We Can Solve the Coronavirus-Test Mess Now—If We Want To
-
Reuters
U.S. SEC awards $2.5 million to Orthofix Medical's external whistleblowers
Previous
